EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver-Targeted AAV-DJ-hCBS Therapy Achieves Long-Term Correction of Metabolic Imbalance in CBS-Deficient Mice

Christian P Joschko iD, Chih-Chieh Wang, Azuwerus van Buiten, Maaike Goris, Femke Hoogstra-Berends, Joy Wang, Jan Henric Bacurio iD, Yinxing Chen, Nannan Jia, June Deng, Shiliang Hu, Mariana Nacht und 3 weitere

International Journal of Molecular Sciences · 07.04.2026 · 27 (7) · 3338

DOI: 10.3390/ijms27073338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.04.2026. Verfasst von Christian P Joschko und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Hauptthemen laut MEDLINE: Cystathionine beta-Synthase, Dependovirus, Homocystinuria, Liver. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Center Groningen, GUIDE, Alexion Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystathionine β-synthase (CBS) deficiency causes classical homocystinuria with severe hyperhomocysteinemia (HHcy) that is inadequately controlled by current therapies. We tested whether liver-targeted CBS gene therapy provides durable biochemical and phenotypic rescue. Using a Cre-inducible adult mouse model of whole-body CBS loss, a single intravenous dose of AAV-DJ-hCBS (3 × 1012 or 3 × 1013 vg/kg) was administered, and the animals were followed for 12 months. Vector biodistribution showed ~100-fold hepatic enrichment over the kidney and spleen. Both doses rapidly normalized plasma homocysteine (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystathionine beta-SynthaseDependovirusHomocystinuriaLiverGenetic TherapyAnimalsMiceGenetic VectorsGene Therapy AgentsDisease Models, AnimalMetabolomicsHyperhomocysteinemia

Stichwörter der Autor:innen

adeno-associated viruscystathionine β-synthasegene therapyhomocystinuriahyperhomocysteinemiamethylationmulti-omicstranssulfuration

Substanzen

Cystathionine beta-Synthase

Autor:innen und Institutionen

  • Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Alexion Pharmaceuticals, AstraZeneca Rare Disease, Genomic Medicine, 100 Binney Street, Cambridge, MA 02142, USA.

ORCID-Profile: Christian P Joschko, Jan Henric Bacurio, Robert H Henning

Förderung

  • University Medical Center Groningen
  • GUIDE
  • Alexion Pharmaceuticals

Zitieren

APA

Joschko, C. P., Wang, C. C., van Buiten, A., Goris, M., Hoogstra-Berends, F., Wang, J., Bacurio, J. H., Chen, Y., Jia, N., Deng, J., Hu, S., Nacht, M., Chiocco, M. J., Henning, R. H., & Deelman, L. E. (2026). Liver-Targeted AAV-DJ-hCBS Therapy Achieves Long-Term Correction of Metabolic Imbalance in CBS-Deficient Mice. International Journal of Molecular Sciences, 27(7), 3338. https://doi.org/10.3390/ijms27073338

Vancouver

Joschko CP, Wang CC, van Buiten A, Goris M, Hoogstra-Berends F, Wang J, et al. Liver-Targeted AAV-DJ-hCBS Therapy Achieves Long-Term Correction of Metabolic Imbalance in CBS-Deficient Mice. International Journal of Molecular Sciences. 2026;27(7):3338. doi:10.3390/ijms27073338

BibTeX
@article{Joschko2026,
  author = {Joschko, Christian P and Wang, Chih-Chieh and van Buiten, Azuwerus and Goris, Maaike and Hoogstra-Berends, Femke and Wang, Joy and Bacurio, Jan Henric and Chen, Yinxing and Jia, Nannan and Deng, June and Hu, Shiliang and Nacht, Mariana and Chiocco, Matthew J and Henning, Robert H and Deelman, Leo E},
  title = {Liver-Targeted AAV-DJ-hCBS Therapy Achieves Long-Term Correction of Metabolic Imbalance in CBS-Deficient Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3338},
  doi = {10.3390/ijms27073338}
}
Kostenlos starten →